Zdrowie i gospodarka · 11/09/2023

FDA Releases Final Guidance for Institutional Review Boards Reviewing Individual Patient Expanded Access Submissions

The FDA has issued a final guidance document to provide clarity on the procedures and key factors Institutional Review Boards (IRBs) should consider when reviewing individual patient expanded access submissions for investigational drugs and biological products.